Epilepsy is a common neurological conditions [1] with a prevalence of 4-10 cases per 1000 persons and an average yearly incidence of 80/100,000 persons [2,3]. Anti-seizure medications (ASMs) are the mainstay epilepsy treatment and there is evidence that they stop seizure in about 70% of people [4]. Across the globe, the World Health Organisation estimates that epilepsy causes 6.4million disability adjusted life years and 1.32 million years of life lost [1]. For people living with epilepsy, it can have significant impacts on daily living such as driving, employment, education, relationships and social participation.
26
ENE
ENE
0